Positive results for CAPTIVATE: ibrutinib and venetoclax for CLL

Paolo Ghia, MD, of the Universit Vita-Salute San Raffaele, Milan, presented preliminary data from the Phase II CAPTIVATE trial (NCT02910583) at the 23rd Congress of the European Hematology Associatio... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts